<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7517806\results\search\disease\results.xml">
  <result pre="People who inject drugs (PWID) are the most exposed to" exact="hepatitis C" post="virus (HCV). In Thailand, drug use is highly criminalized,"/>
  <result pre="of the world population, were estimated to be living with" exact="chronic hepatitis C" post="virus (HCV) infection in 2015 [1]. In 2016, the"/>
  <result pre="the world population, were estimated to be living with chronic" exact="hepatitis C" post="virus (HCV) infection in 2015 [1]. In 2016, the"/>
  <result pre="estimated to be living with chronic hepatitis C virus (HCV)" exact="infection" post="in 2015 [1]. In 2016, the World Health Assembly"/>
  <result pre="Health Assembly adopted a global health sector strategy to combat" exact="viral hepatitis," post="which included eliminating hepatitis C by 2030 [2]. This"/>
  <result pre="health sector strategy to combat viral hepatitis, which included eliminating" exact="hepatitis C" post="by 2030 [2]. This strategy followed the advent of"/>
  <result pre="HCV epidemic in many countries [1]. The prevalence of HCV" exact="infection" post="among people who inject drugs (PWID) ranges from 65%"/>
  <result pre="80% globally [9]. In high-income countries, 50â€&quot;80% of new HCV" exact="infections" post="are found among PWID [10]. Yet despite being the"/>
  <result pre="HCV among PWIDâ€&quot;their access to screening and treatment remains excessively" exact="limited" post="worldwide [11]. Following the World Health Organizationâ€™s publication of"/>
  <result pre="World Health Organizationâ€™s publication of a regional action plan for" exact="viral hepatitis" post="in South-East Asia [12], the Thai Ministry of Public"/>
  <result pre="Health Organizationâ€™s publication of a regional action plan for viral" exact="hepatitis" post="in South-East Asia [12], the Thai Ministry of Public"/>
  <result pre="population might be at odds with law enforcement policies. Since" exact="chronic" post="HCV infection is usually silent during the first decades"/>
  <result pre="be at odds with law enforcement policies. Since chronic HCV" exact="infection" post="is usually silent during the first decades of infection,"/>
  <result pre="specialists who usually do not venture into the field of" exact="infectious diseases." post="The prevalence of HCV in the general population in"/>
  <result pre="at 1â€&quot;3% [15â€&quot;17], representing around 350,000 individuals with active HCV" exact="infection" post="[18]. Several studies have identified injection drug use as"/>
  <result pre="injection drug use as the main risk factor of new" exact="infection" post="[19, 20]. The estimated number of PWID ranges from"/>
  <result pre="Thailand found low rates coupled with low awareness of the" exact="disease" post="[29â€&quot;31], suggesting that most PWID infected with HCV do"/>
  <result pre="and health education have proven effective in reducing HIV and" exact="viral hepatitis" post="transmission by more than 50% among PWID, provided these"/>
  <result pre="health education have proven effective in reducing HIV and viral" exact="hepatitis" post="transmission by more than 50% among PWID, provided these"/>
  <result pre="did not collect information on HCV, which is a major" exact="infectious" post="risk in this population. The knowledge of the HCV"/>
  <result pre="of the stigma and illicitness of their activity, and the" exact="absence of" post="a sampling frame [49]. We selected participants who met"/>
  <result pre="(weights). Each participant is invited to recruit a fixed and" exact="limited" post="number of peers from his or her social network,"/>
  <result pre="of peers from his or her social network, and this" exact="limited" post="number reduces biases seen in other chain-referral methods. While"/>
  <result pre="on. In compliance with the RDS method, participants received a" exact="primary" post="incentive of THB (Thai bahts) 200 (USD 6.4) for"/>
  <result pre="(Thai bahts) 200 (USD 6.4) for their participation and a" exact="secondary" post="incentive of THB 50 (USD 1.6) for each peer"/>
  <result pre="blood or needle sharing, but only 23% could mention accurate" exact="hepatitis C" post="symptoms. The multivariate analysis (Table 4) showed that knowledge"/>
  <result pre="screening Of the 56 participants who had heard of HCV" exact="infection" post="before the study, 15 reported having previously been tested"/>
  <result pre="of whom did not have Thai nationality and therefore had" exact="limited" post="access to the health system. Membership of an ethnic"/>
  <result pre="to PWID willing to participate and that prevention information on" exact="infectious diseases" post="in these centres should be provided. As with other"/>
  <result pre="professionals in these centres be trained to provide information on" exact="infectious" post="risks linked with injection drug use and that they"/>
  <result pre="and decentralizing services, especially in the fields of addictions and" exact="infectious diseases," post="along with increased involvement of primary health care [18],"/>
  <result pre="of addictions and infectious diseases, along with increased involvement of" exact="primary" post="health care [18], might be necessary to simplify access"/>
  <result pre="PWID in Bangkok at 33% [31], and yet another among" exact="HIV-positive" post="PWID in Bangkok at 52.2% [30]. Compared to our"/>
  <result pre="information LINK Additional file 1. Abbreviations DAAs Direct-Acting Antivirals HCV" exact="Hepatitis" post="C Virus NGO Non-Governmental Organization MOUD Medication for Opioid"/>
  <result pre="C Virus NGO Non-Governmental Organization MOUD Medication for Opioid Use" exact="Disorder" post="PWID People Who Inject Drugs RDS Respondent-Driven Sampling Publisherâ€™s"/>
  <result pre="have no competing interests. References References 1.collab: World Health OrganizationGlobal" exact="hepatitis" post="report, 20172017 2.collab: World Health Organization (WHO)Global health sector"/>
  <result pre="20172017 2.collab: World Health Organization (WHO)Global health sector strategy on" exact="viral hepatitis" post="2016â€&quot;2021: towards ending viral hepatitis2016 3.Falade-nwuliaOet al.Oral direct-acting agent"/>
  <result pre="2.collab: World Health Organization (WHO)Global health sector strategy on viral" exact="hepatitis" post="2016â€&quot;2021: towards ending viral hepatitis2016 3.Falade-nwuliaOet al.Oral direct-acting agent"/>
  <result pre="(WHO)Global health sector strategy on viral hepatitis 2016â€&quot;2021: towards ending" exact="viral" post="hepatitis2016 3.Falade-nwuliaOet al.Oral direct-acting agent therapy for hepatitis C"/>
  <result pre="towards ending viral hepatitis2016 3.Falade-nwuliaOet al.Oral direct-acting agent therapy for" exact="hepatitis C" post="virus infection: a systematic reviewAnn Intern Med2018166963764810.7326/M16-2575 4.collab: World"/>
  <result pre="Intern Med2018166963764810.7326/M16-2575 4.collab: World Health Organization (WHO)Progress report on HIV," exact="viral hepatitis" post="and sexually transmitted infections, 20192019 5.HillAKhooSFortunakJSimmonsBFordNMinimum costs for producing"/>
  <result pre="Med2018166963764810.7326/M16-2575 4.collab: World Health Organization (WHO)Progress report on HIV, viral" exact="hepatitis" post="and sexually transmitted infections, 20192019 5.HillAKhooSFortunakJSimmonsBFordNMinimum costs for producing"/>
  <result pre="hepatitis and sexually transmitted infections, 20192019 5.HillAKhooSFortunakJSimmonsBFordNMinimum costs for producing" exact="hepatitis C" post="direct-acting antivirals for use in large-scale treatment access programs"/>
  <result pre="in Bangkok and Chiang MaiDrug Alcohol Depend2015148412613510.1016/j.drugalcdep.2014.12.03425640153 9.HaganHPougetERDes JarlaisDCLelutiu-WeinbergerCMeta-regression of" exact="hepatitis" post="c virus infection in relation to time since onset"/>
  <result pre="and Chiang MaiDrug Alcohol Depend2015148412613510.1016/j.drugalcdep.2014.12.03425640153 9.HaganHPougetERDes JarlaisDCLelutiu-WeinbergerCMeta-regression of hepatitis c" exact="virus infection" post="in relation to time since onset of illicit drug"/>
  <result pre="Chiang MaiDrug Alcohol Depend2015148412613510.1016/j.drugalcdep.2014.12.03425640153 9.HaganHPougetERDes JarlaisDCLelutiu-WeinbergerCMeta-regression of hepatitis c virus" exact="infection" post="in relation to time since onset of illicit drug"/>
  <result pre="influence of time and placeAm J Epidemiol2008168101099110910.1093/aje/kwn23718849303 10.ShepardCWFinelliLAlterMJGlobal epidemiology of" exact="hepatitis C" post="virus infectionLancet Infect Dis20055955856710.1016/S1473-3099(05)70216-416122679 11.AspinallEJet al.Treatment of hepatitis C"/>
  <result pre="of hepatitis C virus infectionLancet Infect Dis20055955856710.1016/S1473-3099(05)70216-416122679 11.AspinallEJet al.Treatment of" exact="hepatitis C" post="virus infection among people who are actively injecting drugs:"/>
  <result pre="C virus infectionLancet Infect Dis20055955856710.1016/S1473-3099(05)70216-416122679 11.AspinallEJet al.Treatment of hepatitis C" exact="virus infection" post="among people who are actively injecting drugs: a systematic"/>
  <result pre="virus infectionLancet Infect Dis20055955856710.1016/S1473-3099(05)70216-416122679 11.AspinallEJet al.Treatment of hepatitis C virus" exact="infection" post="among people who are actively injecting drugs: a systematic"/>
  <result pre="Organization (WHO)collab: Regional Office for South-East AsiaRegional action plan for" exact="viral hepatitis" post="in South-East Asia: 2016â€&quot;20212017 13.collab: Ministry of Public HealthThailand"/>
  <result pre="(WHO)collab: Regional Office for South-East AsiaRegional action plan for viral" exact="hepatitis" post="in South-East Asia: 2016â€&quot;20212017 13.collab: Ministry of Public HealthThailand"/>
  <result pre="Asia: 2016â€&quot;20212017 13.collab: Ministry of Public HealthThailand National strategy on" exact="viral hepatitis" post="prevention and control, 2017â€&quot;20212019 14.PunpanichWUngchusakKDetelsRThailandâ€™s response to the HIV"/>
  <result pre="2016â€&quot;20212017 13.collab: Ministry of Public HealthThailand National strategy on viral" exact="hepatitis" post="prevention and control, 2017â€&quot;20212019 14.PunpanichWUngchusakKDetelsRThailandâ€™s response to the HIV"/>
  <result pre="the HIV epidemic: yesterday, today, and tomorrow2004119136 15.PetruzzielloAMariglianoSLoquercioGCozzolinoACacciapuotiCGlobal epidemiology of" exact="hepatitis C" post="virus infection: An up-date of the distribution and circulation"/>
  <result pre="virus infection: An up-date of the distribution and circulation of" exact="hepatitis C" post="virus genotypesWorld J Gastroenterol20162234782410.3748/wjg.v22.i34.782427678366 16.GowerEEstesCBlachSRazavi-ShearerKRazaviHGlobal epidemiology and genotype distribution"/>
  <result pre="genotypesWorld J Gastroenterol20162234782410.3748/wjg.v22.i34.782427678366 16.GowerEEstesCBlachSRazavi-ShearerKRazaviHGlobal epidemiology and genotype distribution of the" exact="hepatitis C" post="virus infectionJ Hepatol2014611S45S5710.1016/j.jhep.2014.07.02725086286 17.WasitthankasemRet al.Decreasing hepatitis C virus infection"/>
  <result pre="distribution of the hepatitis C virus infectionJ Hepatol2014611S45S5710.1016/j.jhep.2014.07.02725086286 17.WasitthankasemRet al.Decreasing" exact="hepatitis C" post="virus infection in Thailand in the past decade: evidence"/>
  <result pre="the hepatitis C virus infectionJ Hepatol2014611S45S5710.1016/j.jhep.2014.07.02725086286 17.WasitthankasemRet al.Decreasing hepatitis C" exact="virus infection" post="in Thailand in the past decade: evidence from the"/>
  <result pre="hepatitis C virus infectionJ Hepatol2014611S45S5710.1016/j.jhep.2014.07.02725086286 17.WasitthankasemRet al.Decreasing hepatitis C virus" exact="infection" post="in Thailand in the past decade: evidence from the"/>
  <result pre="decade: evidence from the 2014 National SurveyPLoS One2016112e014936210.1371/journal.pone.014936226871561 18.WasitthankasemRet al.Liver" exact="disease" post="burden and required treatment expenditures for hepatitis C virus"/>
  <result pre="One2016112e014936210.1371/journal.pone.014936226871561 18.WasitthankasemRet al.Liver disease burden and required treatment expenditures for" exact="hepatitis C" post="virus (HCV) infection in Thailand: implications for HCV elimination"/>
  <result pre="burden and required treatment expenditures for hepatitis C virus (HCV)" exact="infection" post="in Thailand: implications for HCV elimination in the new"/>
  <result pre="new therapeutic era, a population-based studyPLoS One201813411410.1371/journal.pone.0196301 19.JamiesonDJet al.Infection with" exact="hepatitis C" post="virus among HIV-infected pregnant women in ThailandInfect Dis Obstet"/>
  <result pre="pregnant women in ThailandInfect Dis Obstet Gynecol200820081710.1155/2008/840948 20.TanwandeeTPiratvisuthTPhornphutkulKMairiangPPermpikulPPoovorawanYRisk factors of" exact="hepatitis C" post="virus infection in blood donors in Thailand: a multicenter"/>
  <result pre="in ThailandInfect Dis Obstet Gynecol200820081710.1155/2008/840948 20.TanwandeeTPiratvisuthTPhornphutkulKMairiangPPermpikulPPoovorawanYRisk factors of hepatitis C" exact="virus infection" post="in blood donors in Thailand: a multicenter case-control studyJ"/>
  <result pre="ThailandInfect Dis Obstet Gynecol200820081710.1155/2008/840948 20.TanwandeeTPiratvisuthTPhornphutkulKMairiangPPermpikulPPoovorawanYRisk factors of hepatitis C virus" exact="infection" post="in blood donors in Thailand: a multicenter case-control studyJ"/>
  <result pre="results from national household surveysDrug Alcohol Rev20183721610.1111/dar.12689 25.JittiwutikarnJet al.Hepatitis C" exact="infection" post="among drug users in northern ThailandAm J Trop Med"/>
  <result pre="ThailandAm J Trop Med Hyg20067461111111610.4269/ajtmh.2006.74.111116760529 26.JacksonJBet al.Prevalence and seroincidence of" exact="hepatitis" post="B and hepatitis C infection in high risk people"/>
  <result pre="Med Hyg20067461111111610.4269/ajtmh.2006.74.111116760529 26.JacksonJBet al.Prevalence and seroincidence of hepatitis B and" exact="hepatitis C" post="infection in high risk people who inject drugs in"/>
  <result pre="26.JacksonJBet al.Prevalence and seroincidence of hepatitis B and hepatitis C" exact="infection" post="in high risk people who inject drugs in China"/>
  <result pre="drugs in China and ThailandHepat Res Treat2014201429695810.1155/2014/29695824860664 27.MartinMet al.Hepatitis C" exact="virus infection" post="among people who inject drugs in Bangkok, Thailand, 2005-2010WHO"/>
  <result pre="in China and ThailandHepat Res Treat2014201429695810.1155/2014/29695824860664 27.MartinMet al.Hepatitis C virus" exact="infection" post="among people who inject drugs in Bangkok, Thailand, 2005-2010WHO"/>
  <result pre="2005-2010WHO South-East Asia J public Heal201981505510.4103/2224-3151.255350 28.NelsonPKet al.Global epidemiology of" exact="hepatitis" post="B and hepatitis C in people who inject drugs:"/>
  <result pre="J public Heal201981505510.4103/2224-3151.255350 28.NelsonPKet al.Global epidemiology of hepatitis B and" exact="hepatitis C" post="in people who inject drugs: results of systematic reviewsLancet201137857158310.1016/S0140-6736(11)61097-021802134"/>
  <result pre="of systematic reviewsLancet201137857158310.1016/S0140-6736(11)61097-021802134 29.Khampang R, et al. Uptake of HIV," exact="Hepatitis" post="B and Hepatitis C testing among injection drug users"/>
  <result pre="29.Khampang R, et al. Uptake of HIV, Hepatitis B and" exact="Hepatitis" post="C testing among injection drug users in Thailand. Int"/>
  <result pre="Prev Treat Subst Use Disord. 2015;1(3â€&quot;4):38â€&quot;54. 30.HayashiKet al.Low uptake of" exact="hepatitis C" post="testing and high prevalence of risk behavior among HIV-positive"/>
  <result pre="hepatitis C testing and high prevalence of risk behavior among" exact="HIV-positive" post="injection drug users in Bangkok, ThailandJ Acquir Immune Defic"/>
  <result pre="in Bangkok, ThailandJ Acquir Immune Defic Syndr2011565e133e13510.1097/QAI.0b013e31820bb1e522046605 31.TiLKaplanKHayashiKSuwannawongPWoodEKerrTLow rates of" exact="hepatitis C" post="testing among people who inject drugs in Thailand: implications"/>
  <result pre="M. Needle syringe programmes and opioid substitution therapy for preventing" exact="hepatitis C" post="transmission in people who inject drugs. Cochrane Database Syst"/>
  <result pre="ThailandDrug Alcohol Rev201029215716110.1111/j.1465-3362.2009.00093.x20447223 39.VoonPet al.High prevalence of syringe lending among" exact="HIV-positive" post="people who inject drugs in Bangkok, ThailandHarm Reduct J2015121510.1186/s12954-015-0050-5"/>
  <result pre="drug users in the United StatesAIDS Behav201216479780610.1007/s10461-012-0147-822350828 53.WHO/UNAIDS. Introduction to" exact="HIV/AIDS" post="and sexually transmitted infection surveillance: Module 4: Introduction to"/>
  <result pre="United StatesAIDS Behav201216479780610.1007/s10461-012-0147-822350828 53.WHO/UNAIDS. Introduction to HIV/AIDS and sexually transmitted" exact="infection" post="surveillance: Module 4: Introduction to Respondent Driven Sampling. Geneva;"/>
 </snippets>
</snippetsTree>
